BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 22095644)

  • 41. (19)F nuclear magnetic resonance and crystallographic studies of 5-fluorotryptophan-labeled anthrax protective antigen and effects of the receptor on stability.
    Chadegani F; Lovell S; Mullangi V; Miyagi M; Battaile KP; Bann JG
    Biochemistry; 2014 Feb; 53(4):690-701. PubMed ID: 24387629
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anthrax lethal factor inhibitors as potential countermeasure of the infection.
    Kumar BV; Malik S; Grandhi P; Dayam R; Sarma JA
    Curr Top Med Chem; 2014; 14(17):1977-89. PubMed ID: 25262802
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of residues constituting the 2beta1 strand of domain II in the biological activity of anthrax protective antigen.
    Khanna H; Chopra AP; Arora N; Chaudhry A; Singh Y
    FEMS Microbiol Lett; 2001 May; 199(1):27-31. PubMed ID: 11356563
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anthrax protective antigen is a calcium-dependent serine protease.
    Storm L; Bikker FJ; Nazmi K; Hulst AG; der Riet-Van Oeveren DV; Veerman ECI; Hays JP; Kaman WE
    Virulence; 2018; 9(1):1085-1091. PubMed ID: 30052476
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anthrax toxin uptake by primary immune cells as determined with a lethal factor-beta-lactamase fusion protein.
    Hu H; Leppla SH
    PLoS One; 2009 Nov; 4(11):e7946. PubMed ID: 19956758
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantitative Determination of Lethal Toxin Proteins in Culture Supernatant of Human Live Anthrax Vaccine Bacillus anthracis A16R.
    Zai X; Zhang J; Liu J; Liu J; Li L; Yin Y; Fu L; Xu J; Chen W
    Toxins (Basel); 2016 Feb; 8(3):. PubMed ID: 26927174
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of the α Clamp in the Protein Translocation Mechanism of Anthrax Toxin.
    Brown MJ; Thoren KL; Krantz BA
    J Mol Biol; 2015 Oct; 427(20):3340-3349. PubMed ID: 26344833
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Secondary Structure Preferences of the Anthrax Toxin Protective Antigen Translocase.
    Das D; Krantz BA
    J Mol Biol; 2017 Mar; 429(5):753-762. PubMed ID: 28115202
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stability of domain 4 of the anthrax toxin protective antigen and the effect of the VWA domain of CMG2 on stability.
    Mamillapalli S; Miyagi M; Bann JG
    Protein Sci; 2017 Feb; 26(2):355-364. PubMed ID: 27874231
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structural biology: anthrax hijacks host receptor.
    Bann JG; Hultgren SJ
    Nature; 2004 Aug; 430(7002):843-4. PubMed ID: 15318206
    [No Abstract]   [Full Text] [Related]  

  • 51. Cryo-EM structure of the fully-loaded asymmetric anthrax lethal toxin in its heptameric pre-pore state.
    Antoni C; Quentin D; Lang AE; Aktories K; Gatsogiannis C; Raunser S
    PLoS Pathog; 2020 Aug; 16(8):e1008530. PubMed ID: 32810181
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monitoring the kinetics of the pH-driven transition of the anthrax toxin prepore to the pore by biolayer interferometry and surface plasmon resonance.
    Naik S; Brock S; Akkaladevi N; Tally J; McGinn-Straub W; Zhang N; Gao P; Gogol EP; Pentelute BL; Collier RJ; Fisher MT
    Biochemistry; 2013 Sep; 52(37):6335-47. PubMed ID: 23964683
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of toxin functional domains in anthrax pathogenesis.
    Brossier F; Weber-Levy M; Mock M; Sirard JC
    Infect Immun; 2000 Apr; 68(4):1781-6. PubMed ID: 10722564
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Three dimensional structure of the anthrax toxin translocon-lethal factor complex by cryo-electron microscopy.
    Gogol EP; Akkaladevi N; Szerszen L; Mukherjee S; Chollet-Hinton L; Katayama H; Pentelute BL; Collier RJ; Fisher MT
    Protein Sci; 2013 May; 22(5):586-94. PubMed ID: 23494942
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lethal factor of anthrax toxin binds monomeric form of protective antigen.
    Chvyrkova I; Zhang XC; Terzyan S
    Biochem Biophys Res Commun; 2007 Aug; 360(3):690-5. PubMed ID: 17617379
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mapping dominant-negative mutations of anthrax protective antigen by scanning mutagenesis.
    Mourez M; Yan M; Lacy DB; Dillon L; Bentsen L; Marpoe A; Maurin C; Hotze E; Wigelsworth D; Pimental RA; Ballard JD; Collier RJ; Tweten RK
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):13803-8. PubMed ID: 14623961
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Probing the S2' Subsite of the Anthrax Toxin Lethal Factor Using Novel N-Alkylated Hydroxamates.
    Kurbanov EK; Chiu TL; Solberg J; Francis S; Maize KM; Fernandez J; Johnson RL; Hawkinson JE; Walters MA; Finzel BC; Amin EA
    J Med Chem; 2015 Nov; 58(21):8723-33. PubMed ID: 26492514
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of a receptor-binding region within domain 4 of the protective antigen component of anthrax toxin.
    Varughese M; Teixeira AV; Liu S; Leppla SH
    Infect Immun; 1999 Apr; 67(4):1860-5. PubMed ID: 10085028
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structure of anthrax lethal toxin prepore complex suggests a pathway for efficient cell entry.
    Fabre L; Santelli E; Mountassif D; Donoghue A; Biswas A; Blunck R; Hanein D; Volkmann N; Liddington R; Rouiller I
    J Gen Physiol; 2016 Oct; 148(4):313-24. PubMed ID: 27670897
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Roles of Anthrax Toxin Receptor 2 in Anthrax Toxin Membrane Insertion and Pore Formation.
    Sun J; Jacquez P
    Toxins (Basel); 2016 Jan; 8(2):34. PubMed ID: 26805886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.